(Q43682296)

English

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Röhn TA

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Wagenknecht B

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Roth W

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Naumann U

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Krammer PH

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Walczak H

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Weller M

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4128-4137

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204534

0 references

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

APO2 ligand: a novel lethal weapon against malignant glioma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Glioma cell sensitivity to topotecan: the role of p53 and topotecan-induced DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

21 January 2018

Criteria for analyzing interactions between biologically active agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

7 January 2021

based on heuristic

inferred from DOI database lookup

CD95 ligand: lethal weapon against malignant glioma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204534

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1204534

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43682296&oldid=2102480396"